Therapeutic plasma exchange for the treatment of rapidly progressive glomerulonephritis

Therapeutic Apheresis

Volumn 1, Issue 3, 1997, Pages 255-259

  Kaplan, Andre A ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Antineutrophil cytoplasmic antibody; Glomerulonephritis; Plasma exchange; Plasmapheresis; Rapidly progressing glomerulonephritis; Renal failure

Indexed keywords

ANTIBODY; ANTIGLOMERULAR BASEMENT MEMBRANE ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY;

BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; DISEASE COURSE; FOLLOW UP; GLOMERULONEPHRITIS; GLOMERULUS; HUMAN; IMMUNOLOGY; PLASMAPHERESIS; REVIEW; TREATMENT OUTCOME;

ANTIBODIES; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CLINICAL TRIALS; DISEASE PROGRESSION; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS; HUMANS; KIDNEY GLOMERULUS; PLASMA EXCHANGE; TREATMENT OUTCOME;

EID: 0031195873     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1744-9987.1997.tb00148.x     Document Type: Article

References (47)

1. Couser WG. Rapidly progressive glomerulonephritis, classification, pathogenetic mechanisms and therapy. Am J Kidney Dis 1988;11:449-64.
2. Glassock RJ. Intensive plasma exchange in crescentic glomerulonephritis: Help or no help? Am J Kidney Dis 1992;20:270.
3. Mokrzycki MH, Kaplan AA. Therapeutic plasma exchange: Complications and management. Am J Kidney Dis 1994;23: 817-27.
4. Johnson JP, Moore JJ, Austin H III, Balow JE, Antonovych TT, Wilson CB. Therapy of anti-glomerular basement membrane disease: Analysis of prognostic significance of clinical, pathologic and treatment factors. Medicine 1985;64:219-27.
5. Savage CO, Pusey CD, Bowman C, Rees AJ, Lockwood CM. Antiglomerular basement membrane antibody-mediated disease in the British Isles 1980-4. Br Med J 1986;292:301-4.
6. Simpson IJ, Doak PB, Williams LC, Blacklock HA, Hill RS, Teague CA, Herdson PB, Wilson CB. Plasma exchange in Goodpasture's syndrome. Am J Nephrol 1982;2:301-11.
7. Lockwood CM, Rees AJ, Pearson TA, et al. Immunosuppression and plasma exchange in the treatment of Goodpasture's syndrome. Lancet 1976;1:711-4.
8. Maxwell AP, Nelson WE, Hill CM. Reversal of renal failure in nephritis associated with antibodies to glomerular basement membrane. Br Med J 1988;297:333-4.
9. Madore F, Lazarus JM, Brady HR. Therapeutic plasma exchange in renal disease. J Am Soc Nephrol 1996;7:367-86.
10. Galla JH. IgA nephropathy. Kidney Int 1995;47:377-87.
11. Hene RJ, Kater L. Plasmapheresis in nephritis associated with Henoch Schönlein purpura and in primary IgA nephropathy. Plasma Ther Transfus Technol 1983;4:165-173.
12. Coppo R, Basolo B, Roccatello D, Piccoli G. Plasma exchange in primary IgA nephropathy and Henoch-Schönlein syndrome nephritis. Plasma Ther Transfus Technol 1985;6: 705-23.
13. Coppo R, Basolo B, Giachino O, Roccatello D, Lajolo D, Mazzucco G, Amore A, Piccoli G. Plasmapheresis in a patient with rapidly progressive idiopathic IgA nephropathy: Removal of IgA-containing circulating immune complexes and clinical recovery. Nephron 1985;40:488-90.
14. Nicholls K, Becker G, Walker R, Wright C, Kincaid-Smith P. Plasma exchange in progressive IgA nephropathy. J Clin Apheresis 1990;5:128-32.
15. Jones JV, Cumming RH, Bucknall RC, Asplin CM, Fraser ID, Bothamley J, Davis P, Hamblin TJ. Plasmapheresis in the management of acute systemic lupus erythematosus? Lancet 1976;1:709-11.
16. Jones JV, Cumming RH, Bacon PA, Evers J, Fraser ID, Bothamley J, Tribe CR, Davis P, Huges GRV. Evidence for a therapeutic effect of plasmapheresis in patients with systemic lupus erythematosus. Quart J Med 1979;192:555-76.
17. Jones JV, Robinson MF, Parciany RK, Layfer LF, McLeod B. Therapeutic plasmapheresis in systemic lupus erythematosus. Arth Rheum 1981;24:1113-20.
18. Abdou NI, Lindsley HB, Pollock A, Stechschulte DJ, Wood G. Plasmapheresis in active lupus erythematosus: Effect on clinical, serum and cellular abnormalities. Case report. Clin Immunol Immunopath 1981;19:44-54.
19. Leaker BR, Becker GJ, Dowling JP, Kincaid-Smith PS. Rapid improvement in severe lupus glomerular lesions following intensive plasma exchange associated with immunosuppression. Clin Nephrol 1986;25:236-44.
20. Wei N, Klippel JH, Huston DP, Hall RP, Lawley TJ, Balow JE, Steinberg AD, Decker JL. Randomized trial of plasma exchange in mild systemic lupus erythematosus. Lancet 1983;1:17-21.
21. French Collaborative Group. A randomized trial of plasma exchange in severe acute systemic lupus erythematosus: methodology and interim analysis. Transfus Technol 1985;6:535-9.
22. Lewis EJ, Hunsicker LG, Lan SP, Rohde RD, Lachin JM, Lupus Nephritis Collaborative Study Group. A controlled trial of plasmapheresis therapy in severe lupus nephritis. N Engl J Med 1992;326:1373-9.
23. Euler HH, Schroeder JO, Harten P, Zeuner RA, Gutschmidt HJ. Treatment-free remission in severe systemic lupus erythematosus following synchronization of plasmapheresis with subsequent pulse cyclophosphamide. Arth Rheum 1994;37: 1784-94.
24. Malchesky PS, Clough JD. Cryoglobulins: Properties, prevalence in disease and removal. Cleve Clin Q 1985;2:175-92.
25. Misiani R, Bellavita P, Fenili D, Borelli G, Marchesi D, Massazza M, Vendramin G, Commotti B, Tfanzi E, Scudeller G, Zanetti A. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intens Med 1992;117:573-7.
26. Gilcher RO, Strauss RG, Ciavarella D, Kasprisin DO, Kiprov DD, Klein HG, McLeod BC. Management of renal disorders. J Clin Apheresis 1993;8:258-69.
27. Solomon A, Fahey JL. Plasmapheresis therapy in macroglobulinemia. Ann Intern Med 1963;58:789-800.
28. Lockwood CM. Lymphoma, cryoglobulinemia and renal disease. Kidney Int 1979;16:522-30.
29. Berkman EM, Orlin JB. Use of plasmapheresis and partial plasma exchange in the management of patients with cryoglobulinemia. Transfusion 1979;20:171-8.
30. Geltner D, Kohn RW, Gorevic P, Franklin EC. The effect of combination therapy (steroids, immunosuppressives and plasmapheresis) on 5 mixed cryoglobulinemia patients with renal, neurologic and vascular involvement. Arth Rheum 1984;24: 1121-7.
31. D'Amico G, Ferrario F, Colasanti G, Bucci A. Glomerulonephritis in essential mixed cryoglobulinemia. In: Davison PJ, Guillon PJ, eds. Proceedings of the XXI Congress of the European Dialysis and Transplant Association. London: Pitman, 1984:527-48.
32. Evans TW, Nicholls AJ, Shortland JR, Ward AM, Brown CB. Acute renal failure in essential mixed cryoglobulinemia: Precipitation and reversal by plasma exchange. Clin Nephrol 1984;21:287-93.
33. Ferri C, Moriconi L, Gremignai G, Migliorini P, Paleologo G, Fosellar PV, Bombardieri S. Treatment of the renal involvement in mixed cryoglobulinemia with prolonged plasma exchange. Nephron 1986;43:246-53.
34. D'Amico G, Colasanti G, Ferrario F, Sinico RA. Renal involvement in essential mixed cryoglobulinemia. Kidney Int 1989;35:1004-14.
35. Frankel AH, Singer DRJ, Winearls CG, Evans DJ, Rees AJ, Pusey CD. Type II essential mixed cryoglobulinemia: Presentation, treatment and outcome in 13 patients. Q J Med 1992; 82:101-24.
36. Valbonesi M, Garelli S, Montani F, Cefis M, Rossi U. Management of immune-mediated and paraproteinemic diseases by membrane plasma separation and cascade filtration. Vox Sang 1982;43:91-101.
37. Vibert GJ, Wirtz SA, Smith JW, et al. Cryofiltration as an alternative to plasma exchange: Plasma macromolecular solute removal without replacement fluids. In: Nosé Y, Malchesky PS, Smith JW (ed.) Plasmapheresis. Cleveland: ISAO Press, 1983:281-7.
38. McLeod BC, Sassetti RJ. Plasmapheresis with return of cryoglobulin-depleted autologous plasma (cryoglobulinpheresis) in cryoglobulinemia. Blood 1980;55:866-70.
39. Misiani R, Bellavita P, Fenili D, Vicari O, Marchesi D, Sironi PL, Zilio P, Vernocchi A, Massazza M, Vendramin G, Tfanzi E, Zanetti A. Interferon alpha-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994;330: 751.
40. Angangco R, Thiru S, Esnault VL, Short AK, Lockwood CM, Oliveira. Does truly 'idiopathic' crescentic glomerulonephritis exist? Nephrol Dial Transplant 1994;9:630.
41. Lockwood CM, Rees AJ, Pinching AJ, Pussell B, Sweny P, Uff J, Peters DK. Plasma exchange and immunosuppression in the treatment of fulminating immune-complex crescentric nephritis. Lancet 1977;1:63-7.
42. Kincaid-Smith P, D'Apice AJF. Plasmapheresis in rapidly progressive glomerulonephritis. Am J Med 65:564-566.
43. Hind CRK, Paraskevakou H, Lockwood CM, Evans DJ, Peters DK, Rees AJ. Prognosis after immunosuppression of patients with crescentic nephritis requiring dialysis. Lancet 1983;1:263-5.
44. Mauri JM, Gonzales MT, Poveda R, Seron D, Torras J, Andujar J, Andres E, Alsina J. Therapeutic plasma exchange in the treatment of rapidly progressive glomerulonephritis. Plasma Ther Transfus Technol 1985;6:587-91.
45. Glockner WM, Sieberth HG, Wichmann HE, Backes E, Bambauer R, Boesken WH, Bohle A, Daul A, Graben N, Keller F, Klehr U, Kohler H, Metz U, Schultz W, Thoenes W, Vlaho M. Plasma exchange and immunosuppression in rapidly progressive glomerulonephritis: A controlled multi-center study. Clin Nephrol 1988;29:1.
46. Pusey CD, Rees AJ, Evans DJ, Peters DK, Lockwood CM. Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. Kidney Int 1991;40:757.
47. Cole E, Cattran D, Magil A, Greenwood C, Churchill D, Sutton D, Clark W, Morrin P, Posen G, Bernstein K, Dyck R, and the Canadian Apheresis Study Group. A prospective randomized trial of plasma exchange as additive therapy in idiopathic crescentic glomerulonephritis. Am J Kidney Dis 1992; 20:261-9.